首页> BMC cardiovascular disorders> Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry.

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry.

导出 OA

翻译打印收藏纠错

第一作者： Jeehoon,Kang

第一单位： Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea.;Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

作者： Jeehoon,Kang ^[1] ; Jung-Kyu,Han ^[2] ; Han-Mo,Yang ^[2] ; Kyung Woo,Park ^[2] ; Hyun-Jae,Kang ^[2] ; Bon-Kwon,Koo ^[2] ; Eun Ho,Choo ^[3] ; Jong-Young,Lee ^[4] ; Sang-Don,Park ^[5] ; Young-Hyo,Lim ^[6] ; Hyung-Min,Kim ^[7] ; Ji-Hyun,Heo ^[7] ; Hyo-Soo,Kim ^[8]

作者单位： Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea.;Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Republic of Korea. ^[1] Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea. ^[2] Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, Republic of Korea. ^[3] Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. ^[4] Department of Internal Medicine, Inha University Hospital, Incheon, Republic of Korea. ^[5] Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea. ^[6] Daiichi Sankyo Korea Co., Ltd., Seoul, Republic of Korea. ^[7] Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea. hyosoo@snu.ac.kr. ^[8]

关键词 Acute coronary syndrome Observational study Percutaneous coronary intervention Prasugrel

医学主题词人类(Humans);急性冠状动脉综合征(Acute Coronary Syndrome);血小板聚集抑制剂(Platelet Aggregation Inhibitors);嘌呤能P2Y受体拮抗剂(Purinergic P2Y Receptor Antagonists);登记(Registries);治疗结果(Treatment Outcome);药物替代(Drug Substitution)

DOI 10.1186/s12872-022-03034-5

PMID 36624388

发布时间 2024-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交